Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.779998219174139.
The log-likelihood improved by 2.621.
Iteration 2 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.9021.
Step length converged once. Increasing MCMC sample size.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.04786.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree1  degree2  degree3  degree4  degree5  degree6  degree7  degree8 
      27     1343     1099      781      348      351      319      272 
 degree9 degree10 degree11 degree12 degree13 degree14 degree15 degree16 
     201      121       69       40       21        3        2        2 
degree20 
       1 
1 
disease_progression 
H-positive risk:  856 869 116 838 466 122 905 463 136 53 113 63 
H-negative risk:  869 856 905 838 463 466 122 116 113 136 63 53 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
65 new agents 
2 
disease_progression 
H-positive risk:  864 877 120 837 456 123 901 458 135 51 115 63 
H-negative risk:  877 864 901 837 458 456 123 120 115 135 63 51 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 3 1 

clinical_engagement 
diagnosis 
demography 
46 new agents 
3 
disease_progression 
H-positive risk:  862 883 123 837 448 123 899 455 136 53 117 64 
H-negative risk:  883 862 899 837 455 448 123 123 117 136 64 53 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 5 3 

clinical_engagement 
diagnosis 
demography 
62 new agents 
4 
disease_progression 
H-positive risk:  864 888 126 836 444 123 902 447 135 54 117 64 
H-negative risk:  888 864 902 836 447 444 123 126 117 135 64 54 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 7 3 

clinical_engagement 
diagnosis 
demography 
59 new agents 
5 
disease_progression 
H-positive risk:  875 888 125 838 439 124 897 445 134 55 117 63 
H-negative risk:  888 875 897 838 445 439 124 125 117 134 63 55 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 7 6 

clinical_engagement 
diagnosis 
demography 
56 new agents 
6 
disease_progression 
H-positive risk:  884 902 126 834 434 124 893 437 133 55 118 60 
H-negative risk:  902 884 893 834 437 434 124 126 118 133 60 55 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 9 6 

clinical_engagement 
diagnosis 
demography 
65 new agents 
7 
disease_progression 
H-positive risk:  891 905 126 825 432 125 894 432 132 56 122 60 
H-negative risk:  905 891 894 825 432 432 125 126 122 132 60 56 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 12 6 

clinical_engagement 
diagnosis 
demography 
62 new agents 
8 
disease_progression 
H-positive risk:  897 912 126 816 431 127 891 433 132 55 119 61 
H-negative risk:  912 897 891 816 433 431 127 126 119 132 61 55 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 13 7 

clinical_engagement 
diagnosis 
demography 
64 new agents 
9 
disease_progression 
H-positive risk:  901 914 125 815 430 127 887 433 133 56 118 61 
H-negative risk:  914 901 887 815 433 430 127 125 118 133 61 56 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 13 8 

clinical_engagement 
diagnosis 
demography 
64 new agents 
10 
disease_progression 
H-positive risk:  910 917 125 807 431 127 885 427 133 56 122 60 
H-negative risk:  917 910 885 807 427 431 127 125 122 133 60 56 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 16 8 

clinical_engagement 
diagnosis 
demography 
57 new agents 
11 
disease_progression 
H-positive risk:  916 916 125 807 432 130 886 422 133 55 121 57 
H-negative risk:  916 916 886 807 422 432 130 125 121 133 57 55 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 18 11 

clinical_engagement 
diagnosis 
demography 
59 new agents 
12 
disease_progression 
H-positive risk:  917 924 125 807 428 130 883 419 133 56 121 57 
H-negative risk:  924 917 883 807 419 428 130 125 121 133 57 56 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 18 11 

clinical_engagement 
diagnosis 
demography 
48 new agents 
13 
disease_progression 
H-positive risk:  828 852 118 876 421 119 978 419 145 56 130 58 
H-negative risk:  852 828 978 876 419 421 119 118 130 145 58 56 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 18 11 

clinical_engagement 
diagnosis 
demography 
226 new agents 
14 
disease_progression 
H-positive risk:  868 875 123 827 431 124 952 418 143 58 126 55 
H-negative risk:  875 868 952 827 418 431 124 123 126 143 55 58 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 18 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
15 
disease_progression 
H-positive risk:  875 882 123 821 431 123 951 414 144 54 127 55 
H-negative risk:  882 875 951 821 414 431 123 123 127 144 55 54 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 19 15 

clinical_engagement 
diagnosis 
demography 
61 new agents 
16 
disease_progression 
H-positive risk:  878 886 123 822 425 124 949 412 144 56 125 56 
H-negative risk:  886 878 949 822 412 425 124 123 125 144 56 56 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 20 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
17 
disease_progression 
H-positive risk:  885 892 126 822 420 123 953 406 139 57 124 53 
H-negative risk:  892 885 953 822 406 420 123 126 124 139 53 57 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 24 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
18 
disease_progression 
H-positive risk:  889 891 126 816 420 124 953 409 140 58 123 51 
H-negative risk:  891 889 953 816 409 420 124 126 123 140 51 58 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 25 15 

clinical_engagement 
diagnosis 
demography 
48 new agents 
19 
disease_progression 
H-positive risk:  891 894 125 821 421 126 952 402 141 57 121 49 
H-negative risk:  894 891 952 821 402 421 126 125 121 141 49 57 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 25 15 

clinical_engagement 
diagnosis 
demography 
52 new agents 
20 
disease_progression 
H-positive risk:  890 900 125 826 417 125 953 398 141 56 122 47 
H-negative risk:  900 890 953 826 398 417 125 125 122 141 47 56 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 26 15 

clinical_engagement 
diagnosis 
demography 
55 new agents 
21 
disease_progression 
H-positive risk:  889 904 127 826 415 127 954 392 142 57 121 46 
H-negative risk:  904 889 954 826 392 415 127 127 121 142 46 57 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 27 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
22 
disease_progression 
H-positive risk:  891 915 125 826 414 126 947 392 142 55 121 46 
H-negative risk:  915 891 947 826 392 414 126 125 121 142 46 55 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 27 19 

clinical_engagement 
diagnosis 
demography 
58 new agents 
23 
disease_progression 
H-positive risk:  892 922 128 827 411 126 948 389 140 54 116 47 
H-negative risk:  922 892 948 827 389 411 126 128 116 140 47 54 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 29 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
24 
disease_progression 
H-positive risk:  887 930 127 823 407 126 944 397 139 55 118 47 
H-negative risk:  930 887 944 823 397 407 126 127 118 139 47 55 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 30 19 

clinical_engagement 
diagnosis 
demography 
56 new agents 
25 
disease_progression 
H-positive risk:  823 859 112 902 402 120 1009 393 144 56 132 48 
H-negative risk:  859 823 1009 902 393 402 120 112 132 144 48 56 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 29 19 

clinical_engagement 
diagnosis 
demography 
194 new agents 
26 
disease_progression 
H-positive risk:  841 886 111 885 414 120 968 408 137 52 127 51 
H-negative risk:  886 841 968 885 408 414 120 111 127 137 51 52 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 30 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
27 
disease_progression 
H-positive risk:  849 902 113 873 404 122 966 402 138 52 128 51 
H-negative risk:  902 849 966 873 402 404 122 113 128 138 51 52 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 30 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
28 
disease_progression 
H-positive risk:  852 903 115 879 403 121 968 394 138 50 126 51 
H-negative risk:  903 852 968 879 394 403 121 115 126 138 51 50 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 32 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
29 
disease_progression 
H-positive risk:  857 902 116 878 394 125 971 393 136 52 125 51 
H-negative risk:  902 857 971 878 393 394 125 116 125 136 51 52 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 33 20 

clinical_engagement 
diagnosis 
demography 
49 new agents 
30 
disease_progression 
H-positive risk:  852 900 116 882 394 126 971 393 138 52 126 50 
H-negative risk:  900 852 971 882 393 394 126 116 126 138 50 52 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 36 19 

clinical_engagement 
diagnosis 
demography 
58 new agents 
31 
disease_progression 
H-positive risk:  854 900 117 880 393 128 967 394 137 53 127 50 
H-negative risk:  900 854 967 880 394 393 128 117 127 137 50 53 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 35 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
32 
disease_progression 
H-positive risk:  863 900 119 877 391 129 971 391 133 50 126 50 
H-negative risk:  900 863 971 877 391 391 129 119 126 133 50 50 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 35 18 

clinical_engagement 
diagnosis 
demography 
56 new agents 
33 
disease_progression 
H-positive risk:  870 900 120 875 395 129 975 378 134 50 125 49 
H-negative risk:  900 870 975 875 378 395 129 120 125 134 49 50 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 36 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
34 
disease_progression 
H-positive risk:  870 903 119 879 394 134 968 377 134 50 122 50 
H-negative risk:  903 870 968 879 377 394 134 119 122 134 50 50 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 39 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
35 
disease_progression 
H-positive risk:  871 908 119 888 386 135 963 372 138 51 120 49 
H-negative risk:  908 871 963 888 372 386 135 119 120 138 49 51 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 38 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
36 
disease_progression 
H-positive risk:  877 906 119 893 379 136 964 372 138 48 120 48 
H-negative risk:  906 877 964 893 372 379 136 119 120 138 48 48 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 38 20 

clinical_engagement 
diagnosis 
demography 
55 new agents 
37 
disease_progression 
H-positive risk:  824 848 114 942 375 124 1035 366 152 48 123 49 
H-negative risk:  848 824 1035 942 366 375 124 114 123 152 49 48 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 39 20 

clinical_engagement 
diagnosis 
demography 
155 new agents 
38 
disease_progression 
H-positive risk:  839 859 115 918 387 126 1022 365 149 49 123 48 
H-negative risk:  859 839 1022 918 365 387 126 115 123 149 48 49 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 42 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
39 
disease_progression 
H-positive risk:  845 870 116 918 386 125 1024 352 148 46 120 50 
H-negative risk:  870 845 1024 918 352 386 125 116 120 148 50 46 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 44 21 

clinical_engagement 
diagnosis 
demography 
56 new agents 
40 
disease_progression 
H-positive risk:  843 874 116 915 388 126 1024 353 146 45 120 50 
H-negative risk:  874 843 1024 915 353 388 126 116 120 146 50 45 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 45 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
41 
disease_progression 
H-positive risk:  840 870 118 925 382 127 1024 348 149 47 121 49 
H-negative risk:  870 840 1024 925 348 382 127 118 121 149 49 47 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 47 22 

clinical_engagement 
diagnosis 
demography 
49 new agents 
42 
disease_progression 
H-positive risk:  836 871 118 929 379 126 1026 345 152 48 121 49 
H-negative risk:  871 836 1026 929 345 379 126 118 121 152 49 48 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 48 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
43 
disease_progression 
H-positive risk:  840 871 115 935 379 126 1020 343 150 49 124 48 
H-negative risk:  871 840 1020 935 343 379 126 115 124 150 48 49 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 48 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
44 
disease_progression 
H-positive risk:  845 878 115 932 377 124 1014 346 146 48 127 48 
H-negative risk:  878 845 1014 932 346 377 124 115 127 146 48 48 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 48 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
45 
disease_progression 
H-positive risk:  851 883 115 932 376 125 1006 345 145 48 126 48 
H-negative risk:  883 851 1006 932 345 376 125 115 126 145 48 48 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 46 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
46 
disease_progression 
H-positive risk:  853 880 116 935 375 125 1006 348 144 46 124 48 
H-negative risk:  880 853 1006 935 348 375 125 116 124 144 48 46 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 47 25 

clinical_engagement 
diagnosis 
demography 
57 new agents 
47 
disease_progression 
H-positive risk:  860 876 116 937 377 125 995 346 148 45 125 50 
H-negative risk:  876 860 995 937 346 377 125 116 125 148 50 45 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 48 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
48 
disease_progression 
H-positive risk:  869 884 118 938 369 123 993 346 149 41 120 50 
H-negative risk:  884 869 993 938 346 369 123 118 120 149 50 41 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 47 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
49 
disease_progression 
H-positive risk:  803 830 115 993 367 110 1064 342 165 38 124 49 
H-negative risk:  830 803 1064 993 342 367 110 115 124 165 49 38 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 47 24 

clinical_engagement 
diagnosis 
demography 
106 new agents 
50 
disease_progression 
H-positive risk:  809 834 117 970 385 115 1038 361 159 43 123 46 
H-negative risk:  834 809 1038 970 361 385 115 117 123 159 46 43 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 51 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
51 
disease_progression 
H-positive risk:  811 839 116 969 380 114 1027 366 157 46 127 48 
H-negative risk:  839 811 1027 969 366 380 114 116 127 157 48 46 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 50 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
52 
disease_progression 
H-positive risk:  821 843 115 968 376 112 1019 363 156 50 130 47 
H-negative risk:  843 821 1019 968 363 376 112 115 130 156 47 50 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 52 25 

clinical_engagement 
diagnosis 
demography 
61 new agents 
53 
disease_progression 
H-positive risk:  831 840 113 966 370 111 1017 364 159 47 133 49 
H-negative risk:  840 831 1017 966 364 370 111 113 133 159 49 47 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 55 25 

clinical_engagement 
diagnosis 
demography 
58 new agents 
54 
disease_progression 
H-positive risk:  832 843 111 965 370 112 1017 362 161 44 135 48 
H-negative risk:  843 832 1017 965 362 370 112 111 135 161 48 44 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 58 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
55 
disease_progression 
H-positive risk:  834 841 112 965 372 113 1022 356 158 45 133 49 
H-negative risk:  841 834 1022 965 356 372 113 112 133 158 49 45 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 62 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
56 
disease_progression 
H-positive risk:  844 845 112 962 374 114 1006 357 157 44 135 50 
H-negative risk:  845 844 1006 962 357 374 114 112 135 157 50 44 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 63 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
57 
disease_progression 
H-positive risk:  850 848 112 967 368 115 1003 353 161 43 134 46 
H-negative risk:  848 850 1003 967 353 368 115 112 134 161 46 43 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
58 
disease_progression 
H-positive risk:  846 851 113 977 364 116 1001 342 163 45 137 45 
H-negative risk:  851 846 1001 977 342 364 116 113 137 163 45 45 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
59 
disease_progression 
H-positive risk:  844 863 117 972 359 115 1007 336 163 43 138 43 
H-negative risk:  863 844 1007 972 336 359 115 117 138 163 43 43 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
60 
disease_progression 
H-positive risk:  849 863 113 964 361 117 1002 341 166 42 139 43 
H-negative risk:  863 849 1002 964 341 361 117 113 139 166 43 42 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
61 
disease_progression 
H-positive risk:  800 811 104 1023 360 115 1058 335 165 40 146 43 
H-negative risk:  811 800 1058 1023 335 360 115 104 146 165 43 40 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
116 new agents 
62 
disease_progression 
H-positive risk:  804 814 104 1004 372 113 1047 352 157 41 142 50 
H-negative risk:  814 804 1047 1004 352 372 113 104 142 157 50 41 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
63 
disease_progression 
H-positive risk:  802 810 105 1008 365 115 1049 352 158 45 141 50 
H-negative risk:  810 802 1049 1008 352 365 115 105 141 158 50 45 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
54 new agents 
64 
disease_progression 
H-positive risk:  800 808 104 1011 369 114 1046 354 158 44 140 52 
H-negative risk:  808 800 1046 1011 354 369 114 104 140 158 52 44 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
65 
disease_progression 
H-positive risk:  801 810 106 1014 362 112 1047 351 158 47 140 52 
H-negative risk:  810 801 1047 1014 351 362 112 106 140 158 52 47 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
46 new agents 
66 
disease_progression 
H-positive risk:  802 811 104 1013 361 111 1039 359 159 48 141 52 
H-negative risk:  811 802 1039 1013 359 361 111 104 141 159 52 48 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
67 
disease_progression 
H-positive risk:  800 817 108 1011 358 113 1040 353 157 49 144 50 
H-negative risk:  817 800 1040 1011 353 358 113 108 144 157 50 49 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
68 
disease_progression 
H-positive risk:  801 823 107 1003 357 113 1048 355 155 46 142 50 
H-negative risk:  823 801 1048 1003 355 357 113 107 142 155 50 46 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
69 
disease_progression 
H-positive risk:  806 824 108 1004 351 113 1049 348 158 47 140 52 
H-negative risk:  824 806 1049 1004 348 351 113 108 140 158 52 47 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
70 
disease_progression 
H-positive risk:  818 822 107 1002 358 112 1043 341 163 45 138 51 
H-negative risk:  822 818 1043 1002 341 358 112 107 138 163 51 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
71 
disease_progression 
H-positive risk:  820 820 107 1000 354 113 1052 337 164 44 140 49 
H-negative risk:  820 820 1052 1000 337 354 113 107 140 164 49 44 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
55 new agents 
72 
disease_progression 
H-positive risk:  822 810 107 1000 355 113 1053 337 166 46 143 48 
H-negative risk:  810 822 1053 1000 337 355 113 107 143 166 48 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
73 
disease_progression 
H-positive risk:  766 759 99 1060 353 106 1116 339 166 41 150 45 
H-negative risk:  759 766 1116 1060 339 353 106 99 150 166 45 41 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
99 new agents 
74 
disease_progression 
H-positive risk:  757 757 102 1040 375 109 1104 356 162 43 145 50 
H-negative risk:  757 757 1104 1040 356 375 109 102 145 162 50 43 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
75 
disease_progression 
H-positive risk:  767 754 104 1034 369 110 1087 372 161 46 146 50 
H-negative risk:  754 767 1087 1034 372 369 110 104 146 161 50 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
76 
disease_progression 
H-positive risk:  770 757 101 1034 372 109 1077 371 163 47 146 53 
H-negative risk:  757 770 1077 1034 371 372 109 101 146 163 53 47 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
77 
disease_progression 
H-positive risk:  773 765 96 1034 363 107 1083 368 162 50 149 50 
H-negative risk:  765 773 1083 1034 368 363 107 96 149 162 50 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
78 
disease_progression 
H-positive risk:  781 769 97 1028 357 106 1083 369 162 50 148 50 
H-negative risk:  769 781 1083 1028 369 357 106 97 148 162 50 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
61 new agents 
79 
disease_progression 
H-positive risk:  788 761 97 1034 356 106 1085 367 159 50 147 50 
H-negative risk:  761 788 1085 1034 367 356 106 97 147 159 50 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
80 
disease_progression 
H-positive risk:  786 758 98 1039 349 107 1094 358 163 48 147 53 
H-negative risk:  758 786 1094 1039 358 349 107 98 147 163 53 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
81 
disease_progression 
H-positive risk:  785 758 96 1047 343 109 1094 355 163 51 147 52 
H-negative risk:  758 785 1094 1047 355 343 109 96 147 163 52 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
82 
disease_progression 
H-positive risk:  777 758 98 1053 344 107 1096 355 164 51 146 51 
H-negative risk:  758 777 1096 1053 355 344 107 98 146 164 51 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
52 new agents 
83 
disease_progression 
H-positive risk:  771 763 98 1050 341 108 1101 358 160 53 146 51 
H-negative risk:  763 771 1101 1050 358 341 108 98 146 160 51 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
84 
disease_progression 
H-positive risk:  771 757 96 1056 336 108 1093 366 160 56 150 51 
H-negative risk:  757 771 1093 1056 366 336 108 96 150 160 51 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
85 
disease_progression 
H-positive risk:  720 716 89 1100 341 97 1146 365 168 56 151 51 
H-negative risk:  716 720 1146 1100 365 341 97 89 151 168 51 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
98 new agents 
86 
disease_progression 
H-positive risk:  720 723 90 1089 354 95 1119 391 163 60 148 48 
H-negative risk:  723 720 1119 1089 391 354 95 90 148 163 48 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
87 
disease_progression 
H-positive risk:  727 718 92 1086 358 91 1113 397 167 56 147 48 
H-negative risk:  718 727 1113 1086 397 358 91 92 147 167 48 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
88 
disease_progression 
H-positive risk:  721 719 94 1093 361 93 1113 395 160 55 147 49 
H-negative risk:  719 721 1113 1093 395 361 93 94 147 160 49 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
89 
disease_progression 
H-positive risk:  713 720 94 1085 366 95 1120 393 160 54 151 49 
H-negative risk:  720 713 1120 1085 393 366 95 94 151 160 49 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
90 
disease_progression 
H-positive risk:  720 725 94 1089 370 95 1110 387 159 54 149 48 
H-negative risk:  725 720 1110 1089 387 370 95 94 149 159 48 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
91 
disease_progression 
H-positive risk:  723 722 94 1084 371 95 1122 383 159 51 146 50 
H-negative risk:  722 723 1122 1084 383 371 95 94 146 159 50 51 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 68 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
92 
disease_progression 
H-positive risk:  729 725 93 1071 376 96 1125 384 155 53 142 51 
H-negative risk:  725 729 1125 1071 384 376 96 93 142 155 51 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 67 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
93 
disease_progression 
H-positive risk:  732 722 94 1069 374 99 1129 384 153 53 140 51 
H-negative risk:  722 732 1129 1069 384 374 99 94 140 153 51 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 68 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
94 
disease_progression 
H-positive risk:  737 727 95 1073 368 99 1127 385 153 52 136 48 
H-negative risk:  727 737 1127 1073 385 368 99 95 136 153 48 52 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 66 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
95 
disease_progression 
H-positive risk:  745 730 96 1074 369 101 1127 373 154 49 136 46 
H-negative risk:  730 745 1127 1074 373 369 101 96 136 154 46 49 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
96 
disease_progression 
H-positive risk:  747 738 95 1065 371 101 1127 366 154 52 137 47 
H-negative risk:  738 747 1127 1065 366 371 101 95 137 154 47 52 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 62 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
97 
disease_progression 
H-positive risk:  707 696 90 1103 376 92 1170 360 161 54 144 47 
H-negative risk:  696 707 1170 1103 360 376 92 90 144 161 47 54 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 62 25 

clinical_engagement 
diagnosis 
demography 
107 new agents 
98 
disease_progression 
H-positive risk:  702 710 89 1084 393 93 1160 365 156 57 146 45 
H-negative risk:  710 702 1160 1084 365 393 93 89 146 156 45 57 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 60 26 

clinical_engagement 
diagnosis 
demography 
91 new agents 
99 
disease_progression 
H-positive risk:  711 717 90 1070 400 92 1162 360 152 60 142 44 
H-negative risk:  717 711 1162 1070 360 400 92 90 142 152 44 60 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 59 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
100 
disease_progression 
H-positive risk:  715 720 93 1075 397 94 1143 367 151 60 139 46 
H-negative risk:  720 715 1143 1075 367 397 94 93 139 151 46 60 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 60 27 

clinical_engagement 
diagnosis 
demography 
87 new agents 
101 
disease_progression 
H-positive risk:  716 730 93 1068 395 93 1146 366 150 59 142 42 
H-negative risk:  730 716 1146 1068 366 395 93 93 142 150 42 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 65 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
102 
disease_progression 
H-positive risk:  721 730 93 1059 400 93 1141 365 150 60 145 43 
H-negative risk:  730 721 1141 1059 365 400 93 93 145 150 43 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 64 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
103 
disease_progression 
H-positive risk:  733 734 94 1045 397 90 1142 364 152 59 146 44 
H-negative risk:  734 733 1142 1045 364 397 90 94 146 152 44 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 70 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
104 
disease_progression 
H-positive risk:  730 740 96 1041 406 91 1138 356 152 60 147 43 
H-negative risk:  740 730 1138 1041 356 406 91 96 147 152 43 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
63 new agents 
105 
disease_progression 
H-positive risk:  727 741 96 1044 398 86 1145 363 152 59 146 43 
H-negative risk:  741 727 1145 1044 363 398 86 96 146 152 43 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
106 
disease_progression 
H-positive risk:  727 741 95 1045 397 87 1143 363 151 61 148 42 
H-negative risk:  741 727 1143 1045 363 397 87 95 148 151 42 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
107 
disease_progression 
H-positive risk:  728 739 96 1048 395 87 1145 365 148 64 144 41 
H-negative risk:  739 728 1145 1048 365 395 87 96 144 148 41 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
64 new agents 
108 
disease_progression 
H-positive risk:  734 735 98 1042 401 88 1136 370 145 65 145 41 
H-negative risk:  735 734 1136 1042 370 401 88 98 145 145 41 65 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 66 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
109 
disease_progression 
H-positive risk:  699 699 88 1087 402 82 1175 360 152 63 154 39 
H-negative risk:  699 699 1175 1087 360 402 82 88 154 152 39 63 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 67 27 

clinical_engagement 
diagnosis 
demography 
99 new agents 
110 
disease_progression 
H-positive risk:  688 696 87 1081 411 83 1174 368 149 70 150 43 
H-negative risk:  696 688 1174 1081 368 411 83 87 150 149 43 70 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
111 
disease_progression 
H-positive risk:  686 692 90 1072 419 84 1171 373 149 69 152 43 
H-negative risk:  692 686 1171 1072 373 419 84 90 152 149 43 69 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
112 
disease_progression 
H-positive risk:  686 697 89 1077 411 87 1166 372 150 70 153 42 
H-negative risk:  697 686 1166 1077 372 411 87 89 153 150 42 70 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 68 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
113 
disease_progression 
H-positive risk:  694 694 86 1087 416 86 1164 360 148 69 154 42 
H-negative risk:  694 694 1164 1087 360 416 86 86 154 148 42 69 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
114 
disease_progression 
H-positive risk:  700 696 90 1083 412 85 1158 359 148 70 154 45 
H-negative risk:  696 700 1158 1083 359 412 85 90 154 148 45 70 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
58 new agents 
115 
disease_progression 
H-positive risk:  696 698 91 1080 414 85 1156 362 149 71 153 45 
H-negative risk:  698 696 1156 1080 362 414 85 91 153 149 45 71 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
60 new agents 
116 
disease_progression 
H-positive risk:  686 698 93 1089 413 86 1157 367 148 70 149 44 
H-negative risk:  698 686 1157 1089 367 413 86 93 149 148 44 70 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
51 new agents 
117 
disease_progression 
H-positive risk:  683 699 94 1090 413 86 1156 366 148 71 149 45 
H-negative risk:  699 683 1156 1090 366 413 86 94 149 148 45 71 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
74 new agents 
118 
disease_progression 
H-positive risk:  684 696 96 1096 411 86 1147 377 144 71 148 44 
H-negative risk:  696 684 1147 1096 377 411 86 96 148 144 44 71 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
119 
disease_progression 
H-positive risk:  690 702 96 1094 415 87 1130 380 143 70 149 44 
H-negative risk:  702 690 1130 1094 380 415 87 96 149 143 44 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
84 new agents 
120 
disease_progression 
H-positive risk:  688 707 96 1099 407 87 1126 385 138 71 153 43 
H-negative risk:  707 688 1126 1099 385 407 87 96 153 138 43 71 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
76 new agents 
121 
disease_progression 
H-positive risk:  661 672 95 1133 407 79 1162 381 143 70 155 42 
H-negative risk:  672 661 1162 1133 381 407 79 95 155 143 42 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
106 new agents 
122 
disease_progression 
H-positive risk:  679 668 92 1132 416 77 1141 391 139 66 152 47 
H-negative risk:  668 679 1141 1132 391 416 77 92 152 139 47 66 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 70 31 

clinical_engagement 
diagnosis 
demography 
89 new agents 
123 
disease_progression 
H-positive risk:  684 677 90 1118 417 77 1144 392 135 67 152 47 
H-negative risk:  677 684 1144 1118 392 417 77 90 152 135 47 67 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
65 new agents 
124 
disease_progression 
H-positive risk:  678 681 93 1126 409 79 1142 393 131 69 151 48 
H-negative risk:  681 678 1142 1126 393 409 79 93 151 131 48 69 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
94 new agents 
125 
disease_progression 
H-positive risk:  681 695 94 1125 405 80 1135 392 129 68 148 48 
H-negative risk:  695 681 1135 1125 392 405 80 94 148 129 48 68 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
126 
disease_progression 
H-positive risk:  677 695 94 1129 403 79 1142 396 125 64 149 47 
H-negative risk:  695 677 1142 1129 396 403 79 94 149 125 47 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
127 
disease_progression 
H-positive risk:  680 691 95 1131 401 79 1147 393 127 61 146 49 
H-negative risk:  691 680 1147 1131 393 401 79 95 146 127 49 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
128 
disease_progression 
H-positive risk:  687 698 92 1130 405 79 1138 387 127 61 146 50 
H-negative risk:  698 687 1138 1130 387 405 79 92 146 127 50 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 74 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
129 
disease_progression 
H-positive risk:  691 703 91 1134 403 77 1133 386 127 58 147 50 
H-negative risk:  703 691 1133 1134 386 403 77 91 147 127 50 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
59 new agents 
130 
disease_progression 
H-positive risk:  684 710 90 1136 407 76 1134 381 129 57 147 49 
H-negative risk:  710 684 1134 1136 381 407 76 90 147 129 49 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
64 new agents 
131 
disease_progression 
H-positive risk:  686 710 88 1134 409 78 1135 382 123 56 150 49 
H-negative risk:  710 686 1135 1134 382 409 78 88 150 123 49 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
54 new agents 
132 
disease_progression 
H-positive risk:  681 708 87 1139 406 81 1130 388 123 58 150 49 
H-negative risk:  708 681 1130 1139 388 406 81 87 150 123 49 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
63 new agents 
133 
disease_progression 
H-positive risk:  681 697 91 1147 415 83 1126 384 126 55 147 48 
H-negative risk:  697 681 1126 1147 384 415 83 91 147 126 48 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
102 new agents 
134 
disease_progression 
H-positive risk:  677 699 93 1139 425 80 1119 386 127 57 146 52 
H-negative risk:  699 677 1119 1139 386 425 80 93 146 127 52 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
84 new agents 
135 
disease_progression 
H-positive risk:  668 705 92 1126 429 80 1123 389 130 55 149 54 
H-negative risk:  705 668 1123 1126 389 429 80 92 149 130 54 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 71 33 

clinical_engagement 
diagnosis 
demography 
64 new agents 
136 
disease_progression 
H-positive risk:  676 694 92 1134 430 79 1124 387 130 52 149 53 
H-negative risk:  694 676 1124 1134 387 430 79 92 149 130 53 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 71 33 

clinical_engagement 
diagnosis 
demography 
93 new agents 
137 
disease_progression 
H-positive risk:  672 699 92 1136 429 79 1125 385 131 49 151 52 
H-negative risk:  699 672 1125 1136 385 429 79 92 151 131 52 49 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
85 new agents 
138 
disease_progression 
H-positive risk:  669 706 92 1128 432 79 1123 381 131 52 154 53 
H-negative risk:  706 669 1123 1128 381 432 79 92 154 131 53 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
139 
disease_progression 
H-positive risk:  661 705 93 1133 429 76 1131 383 130 53 153 53 
H-negative risk:  705 661 1131 1133 383 429 76 93 153 130 53 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
140 
disease_progression 
H-positive risk:  652 694 92 1143 431 79 1138 384 127 55 152 53 
H-negative risk:  694 652 1138 1143 384 431 79 92 152 127 53 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
141 
disease_progression 
H-positive risk:  665 701 92 1137 426 79 1129 386 128 53 150 54 
H-negative risk:  701 665 1129 1137 386 426 79 92 150 128 54 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
142 
disease_progression 
H-positive risk:  665 701 90 1137 419 75 1137 387 130 55 149 55 
H-negative risk:  701 665 1137 1137 387 419 75 90 149 130 55 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
70 new agents 
143 
disease_progression 
H-positive risk:  657 702 91 1143 408 77 1142 391 134 53 146 56 
H-negative risk:  702 657 1142 1143 391 408 77 91 146 134 56 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 73 34 

clinical_engagement 
diagnosis 
demography 
67 new agents 
144 
disease_progression 
H-positive risk:  661 701 91 1155 404 76 1138 384 135 53 146 56 
H-negative risk:  701 661 1138 1155 384 404 76 91 146 135 56 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 77 34 

clinical_engagement 
diagnosis 
demography 
79 new agents 
145 
disease_progression 
H-positive risk:  665 702 94 1156 395 77 1134 385 133 54 148 57 
H-negative risk:  702 665 1134 1156 385 395 77 94 148 133 57 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 78 34 

clinical_engagement 
diagnosis 
demography 
98 new agents 
146 
disease_progression 
H-positive risk:  665 711 92 1138 408 79 1131 392 128 53 146 57 
H-negative risk:  711 665 1131 1138 392 408 79 92 146 128 57 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 76 34 

clinical_engagement 
diagnosis 
demography 
85 new agents 
147 
disease_progression 
H-positive risk:  663 709 89 1136 409 79 1130 394 131 53 149 58 
H-negative risk:  709 663 1130 1136 394 409 79 89 149 131 58 53 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 72 33 

clinical_engagement 
diagnosis 
demography 
86 new agents 
148 
disease_progression 
H-positive risk:  661 709 89 1144 406 81 1125 390 132 55 150 58 
H-negative risk:  709 661 1125 1144 390 406 81 89 150 132 58 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 73 33 

clinical_engagement 
diagnosis 
demography 
100 new agents 
149 
disease_progression 
H-positive risk:  658 706 93 1143 409 79 1131 384 133 55 151 58 
H-negative risk:  706 658 1131 1143 384 409 79 93 151 133 58 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
85 new agents 
150 
disease_progression 
H-positive risk:  655 708 92 1146 409 80 1124 391 134 52 152 57 
H-negative risk:  708 655 1124 1146 391 409 80 92 152 134 57 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
60 new agents 
151 
disease_progression 
H-positive risk:  656 708 94 1150 408 77 1121 392 135 53 146 60 
H-negative risk:  708 656 1121 1150 392 408 77 94 146 135 60 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
64 new agents 
152 
disease_progression 
H-positive risk:  657 705 95 1143 417 75 1121 390 137 55 145 60 
H-negative risk:  705 657 1121 1143 390 417 75 95 145 137 60 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
65 new agents 
153 
disease_progression 
H-positive risk:  661 702 96 1134 426 72 1113 395 139 58 147 57 
H-negative risk:  702 661 1113 1134 395 426 72 96 147 139 57 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
154 
disease_progression 
H-positive risk:  673 713 96 1124 421 72 1109 392 141 56 145 58 
H-negative risk:  713 673 1109 1124 392 421 72 96 145 141 58 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
155 
disease_progression 
H-positive risk:  682 715 96 1118 424 71 1098 394 142 55 144 61 
H-negative risk:  715 682 1098 1118 394 424 71 96 144 142 61 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 77 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
156 
disease_progression 
H-positive risk:  675 721 98 1114 430 73 1101 390 142 54 143 59 
H-negative risk:  721 675 1101 1114 390 430 73 98 143 142 59 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
81 new agents 
157 
disease_progression 
H-positive risk:  669 719 99 1116 432 75 1103 395 140 52 143 57 
H-negative risk:  719 669 1103 1116 395 432 75 99 143 140 57 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 76 34 

clinical_engagement 
diagnosis 
demography 
81 new agents 
158 
disease_progression 
H-positive risk:  671 707 101 1113 432 71 1101 409 139 54 141 61 
H-negative risk:  707 671 1101 1113 409 432 71 101 141 139 61 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 77 34 

clinical_engagement 
diagnosis 
demography 
88 new agents 
159 
disease_progression 
H-positive risk:  669 704 102 1117 425 71 1104 414 142 57 135 60 
H-negative risk:  704 669 1104 1117 414 425 71 102 135 142 60 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
87 new agents 
160 
disease_progression 
H-positive risk:  673 715 103 1113 409 70 1106 414 145 56 137 59 
H-negative risk:  715 673 1106 1113 414 409 70 103 137 145 59 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
63 new agents 
161 
disease_progression 
H-positive risk:  665 705 101 1136 402 68 1115 410 146 57 134 61 
H-negative risk:  705 665 1115 1136 410 402 68 101 134 146 61 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
162 
disease_progression 
H-positive risk:  668 705 101 1142 392 68 1115 407 147 57 139 59 
H-negative risk:  705 668 1115 1142 407 392 68 101 139 147 59 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
82 new agents 
163 
disease_progression 
H-positive risk:  675 709 98 1136 392 71 1109 398 147 60 144 61 
H-negative risk:  709 675 1109 1136 398 392 71 98 144 147 61 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
164 
disease_progression 
H-positive risk:  678 711 96 1134 394 76 1112 390 144 62 143 60 
H-negative risk:  711 678 1112 1134 390 394 76 96 143 144 60 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
85 new agents 
165 
disease_progression 
H-positive risk:  679 713 96 1136 390 75 1116 389 145 60 144 57 
H-negative risk:  713 679 1116 1136 389 390 75 96 144 145 57 60 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
166 
disease_progression 
H-positive risk:  676 704 99 1146 389 76 1118 387 148 59 139 59 
H-negative risk:  704 676 1118 1146 387 389 76 99 139 148 59 59 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
167 
disease_progression 
H-positive risk:  678 704 97 1145 392 77 1112 389 147 61 141 57 
H-negative risk:  704 678 1112 1145 389 392 77 97 141 147 57 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
85 new agents 
168 
disease_progression 
H-positive risk:  668 709 98 1154 395 76 1108 391 148 59 141 53 
H-negative risk:  709 668 1108 1154 391 395 76 98 141 148 53 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
169 
disease_progression 
H-positive risk:  664 712 99 1152 391 78 1114 392 144 58 142 54 
H-negative risk:  712 664 1114 1152 392 391 78 99 142 144 54 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
92 new agents 
170 
disease_progression 
H-positive risk:  662 721 99 1144 402 78 1096 403 144 58 142 51 
H-negative risk:  721 662 1096 1144 403 402 78 99 142 144 51 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
171 
disease_progression 
H-positive risk:  660 715 100 1152 398 81 1092 409 141 59 142 51 
H-negative risk:  715 660 1092 1152 409 398 81 100 142 141 51 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
172 
disease_progression 
H-positive risk:  668 706 99 1151 400 80 1089 412 141 60 144 50 
H-negative risk:  706 668 1089 1151 412 400 80 99 144 141 50 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
173 
disease_progression 
H-positive risk:  672 702 94 1152 396 82 1089 414 142 60 147 50 
H-negative risk:  702 672 1089 1152 414 396 82 94 147 142 50 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
174 
disease_progression 
H-positive risk:  668 700 93 1141 397 83 1093 424 144 58 150 49 
H-negative risk:  700 668 1093 1141 424 397 83 93 150 144 49 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
175 
disease_progression 
H-positive risk:  672 707 93 1138 395 86 1087 421 149 55 145 52 
H-negative risk:  707 672 1087 1138 421 395 86 93 145 149 52 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
176 
disease_progression 
H-positive risk:  679 700 94 1138 399 87 1079 425 146 54 146 53 
H-negative risk:  700 679 1079 1138 425 399 87 94 146 146 53 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
177 
disease_progression 
H-positive risk:  676 696 91 1145 400 87 1088 416 148 54 145 54 
H-negative risk:  696 676 1088 1145 416 400 87 91 145 148 54 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
178 
disease_progression 
H-positive risk:  680 696 89 1152 396 87 1083 417 142 59 145 54 
H-negative risk:  696 680 1083 1152 417 396 87 89 145 142 54 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
179 
disease_progression 
H-positive risk:  685 690 87 1159 386 88 1087 416 145 57 147 53 
H-negative risk:  690 685 1087 1159 416 386 88 87 147 145 53 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
180 
disease_progression 
H-positive risk:  679 693 86 1159 392 86 1085 417 146 57 149 51 
H-negative risk:  693 679 1085 1159 417 392 86 86 149 146 51 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
181 
disease_progression 
H-positive risk:  681 700 87 1156 392 85 1084 418 146 54 148 49 
H-negative risk:  700 681 1084 1156 418 392 85 87 148 146 49 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
182 
disease_progression 
H-positive risk:  679 693 92 1155 397 87 1080 425 146 52 147 47 
H-negative risk:  693 679 1080 1155 425 397 87 92 147 146 47 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
93 new agents 
183 
disease_progression 
H-positive risk:  681 694 93 1167 381 84 1082 423 148 52 148 47 
H-negative risk:  694 681 1082 1167 423 381 84 93 148 148 47 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
184 
disease_progression 
H-positive risk:  678 689 95 1172 376 85 1084 429 149 50 148 45 
H-negative risk:  689 678 1084 1172 429 376 85 95 148 149 45 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
185 
disease_progression 
H-positive risk:  678 681 94 1176 377 84 1077 433 150 53 151 46 
H-negative risk:  681 678 1077 1176 433 377 84 94 151 150 46 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
186 
disease_progression 
H-positive risk:  675 678 96 1177 383 80 1089 426 151 50 147 48 
H-negative risk:  678 675 1089 1177 426 383 80 96 147 151 48 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
187 
disease_progression 
H-positive risk:  687 676 93 1186 385 81 1076 424 148 51 148 45 
H-negative risk:  676 687 1076 1186 424 385 81 93 148 148 45 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
188 
disease_progression 
H-positive risk:  687 680 95 1182 386 81 1073 421 150 51 148 46 
H-negative risk:  680 687 1073 1182 421 386 81 95 148 150 46 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
189 
disease_progression 
H-positive risk:  688 680 96 1172 389 82 1072 427 152 49 147 46 
H-negative risk:  680 688 1072 1172 427 389 82 96 147 152 46 49 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
190 
disease_progression 
H-positive risk:  683 685 96 1171 388 81 1076 425 155 50 145 45 
H-negative risk:  685 683 1076 1171 425 388 81 96 145 155 45 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
70 new agents 
191 
disease_progression 
H-positive risk:  685 681 94 1163 391 81 1083 429 153 52 144 44 
H-negative risk:  681 685 1083 1163 429 391 81 94 144 153 44 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
192 
disease_progression 
H-positive risk:  680 679 94 1159 395 79 1084 440 149 54 144 43 
H-negative risk:  679 680 1084 1159 440 395 79 94 144 149 43 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
193 
disease_progression 
H-positive risk:  679 687 97 1156 392 78 1086 440 149 51 139 46 
H-negative risk:  687 679 1086 1156 440 392 78 97 139 149 46 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
194 
disease_progression 
H-positive risk:  675 689 99 1141 405 79 1082 447 149 50 137 47 
H-negative risk:  689 675 1082 1141 447 405 79 99 137 149 47 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
195 
disease_progression 
H-positive risk:  670 693 96 1147 405 81 1075 453 146 50 138 46 
H-negative risk:  693 670 1075 1147 453 405 81 96 138 146 46 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
196 
disease_progression 
H-positive risk:  669 696 95 1142 406 82 1075 447 146 52 142 48 
H-negative risk:  696 669 1075 1142 447 406 82 95 142 146 48 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
95 new agents 
197 
disease_progression 
H-positive risk:  666 696 97 1149 397 86 1076 444 143 53 142 51 
H-negative risk:  696 666 1076 1149 444 397 86 97 142 143 51 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
198 
disease_progression 
H-positive risk:  669 692 97 1147 400 85 1084 434 143 55 137 57 
H-negative risk:  692 669 1084 1147 434 400 85 97 137 143 57 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
199 
disease_progression 
H-positive risk:  674 692 96 1147 396 85 1090 430 142 54 141 53 
H-negative risk:  692 674 1090 1147 430 396 85 96 141 142 53 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 76 29 

clinical_engagement 
diagnosis 
demography 
82 new agents 
200 
disease_progression 
H-positive risk:  676 699 96 1146 397 83 1089 426 139 53 140 56 
H-negative risk:  699 676 1089 1146 426 397 83 96 140 139 56 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
201 
disease_progression 
H-positive risk:  669 698 99 1147 390 83 1099 421 140 53 143 58 
H-negative risk:  698 669 1099 1147 421 390 83 99 143 140 58 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
202 
disease_progression 
H-positive risk:  667 699 101 1140 392 86 1096 427 140 51 143 58 
H-negative risk:  699 667 1096 1140 427 392 86 101 143 140 58 51 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
54 new agents 
203 
disease_progression 
H-positive risk:  664 695 100 1151 391 85 1090 432 141 52 142 57 
H-negative risk:  695 664 1090 1151 432 391 85 100 142 141 57 52 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
204 
disease_progression 
H-positive risk:  670 693 99 1145 394 85 1078 438 141 55 145 57 
H-negative risk:  693 670 1078 1145 438 394 85 99 145 141 57 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
205 
disease_progression 
H-positive risk:  670 694 100 1144 395 84 1072 441 140 57 145 58 
H-negative risk:  694 670 1072 1144 441 395 84 100 145 140 58 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
97 new agents 
206 
disease_progression 
H-positive risk:  672 696 101 1135 406 86 1065 441 139 58 143 58 
H-negative risk:  696 672 1065 1135 441 406 86 101 143 139 58 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
207 
disease_progression 
H-positive risk:  667 693 103 1133 407 86 1062 447 141 61 140 60 
H-negative risk:  693 667 1062 1133 447 407 86 103 140 141 60 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
208 
disease_progression 
H-positive risk:  676 694 101 1126 416 86 1060 439 139 63 142 58 
H-negative risk:  694 676 1060 1126 439 416 86 101 142 139 58 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
209 
disease_progression 
H-positive risk:  683 688 100 1126 418 87 1064 437 135 61 144 57 
H-negative risk:  688 683 1064 1126 437 418 87 100 144 135 57 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
210 
disease_progression 
H-positive risk:  688 685 100 1136 414 88 1057 437 135 59 145 56 
H-negative risk:  685 688 1057 1136 437 414 88 100 145 135 56 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
211 
disease_progression 
H-positive risk:  681 685 100 1124 420 91 1066 433 132 65 145 58 
H-negative risk:  685 681 1066 1124 433 420 91 100 145 132 58 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
97 new agents 
212 
disease_progression 
H-positive risk:  677 695 103 1121 421 92 1072 421 128 67 142 61 
H-negative risk:  695 677 1072 1121 421 421 92 103 142 128 61 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
213 
disease_progression 
H-positive risk:  677 695 104 1122 414 96 1087 411 129 64 139 62 
H-negative risk:  695 677 1087 1122 411 414 96 104 139 129 62 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
64 new agents 
214 
disease_progression 
H-positive risk:  680 695 99 1119 420 95 1081 416 125 63 140 67 
H-negative risk:  695 680 1081 1119 416 420 95 99 140 125 67 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 73 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
215 
disease_progression 
H-positive risk:  677 697 97 1124 414 98 1078 423 124 60 141 67 
H-negative risk:  697 677 1078 1124 423 414 98 97 141 124 67 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
216 
disease_progression 
H-positive risk:  674 703 103 1124 412 98 1077 424 123 57 140 65 
H-negative risk:  703 674 1077 1124 424 412 98 103 140 123 65 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
217 
disease_progression 
H-positive risk:  676 702 102 1110 427 100 1074 425 124 55 140 65 
H-negative risk:  702 676 1074 1110 425 427 100 102 140 124 65 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 69 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
218 
disease_progression 
H-positive risk:  678 704 100 1110 428 103 1069 424 122 54 142 66 
H-negative risk:  704 678 1069 1110 424 428 103 100 142 122 66 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 68 31 

clinical_engagement 
diagnosis 
demography 
66 new agents 
219 
disease_progression 
H-positive risk:  679 700 100 1112 428 101 1073 425 122 53 136 71 
H-negative risk:  700 679 1073 1112 425 428 101 100 136 122 71 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
220 
disease_progression 
H-positive risk:  683 700 103 1108 422 98 1074 432 124 53 136 67 
H-negative risk:  700 683 1074 1108 432 422 98 103 136 124 67 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
221 
disease_progression 
H-positive risk:  686 696 102 1109 423 98 1077 431 119 53 137 69 
H-negative risk:  696 686 1077 1109 431 423 98 102 137 119 69 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 76 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
222 
disease_progression 
H-positive risk:  683 699 105 1105 433 98 1076 424 119 55 134 69 
H-negative risk:  699 683 1076 1105 424 433 98 105 134 119 69 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
67 new agents 
223 
disease_progression 
H-positive risk:  688 694 104 1107 430 101 1068 430 120 59 130 69 
H-negative risk:  694 688 1068 1107 430 430 101 104 130 120 69 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
224 
disease_progression 
H-positive risk:  687 705 102 1108 420 100 1066 434 119 59 132 68 
H-negative risk:  705 687 1066 1108 434 420 100 102 132 119 68 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
225 
disease_progression 
H-positive risk:  684 716 104 1092 428 100 1071 430 118 60 129 68 
H-negative risk:  716 684 1071 1092 430 428 100 104 129 118 68 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
226 
disease_progression 
H-positive risk:  680 708 103 1096 432 103 1076 423 120 63 128 68 
H-negative risk:  708 680 1076 1096 423 432 103 103 128 120 68 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
227 
disease_progression 
H-positive risk:  682 713 101 1094 421 101 1083 426 120 60 134 65 
H-negative risk:  713 682 1083 1094 426 421 101 101 134 120 65 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
228 
disease_progression 
H-positive risk:  694 705 100 1090 432 103 1072 428 120 60 133 63 
H-negative risk:  705 694 1072 1090 428 432 103 100 133 120 63 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
229 
disease_progression 
H-positive risk:  698 695 100 1080 439 106 1075 426 121 60 137 63 
H-negative risk:  695 698 1075 1080 426 439 106 100 137 121 63 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
91 new agents 
230 
disease_progression 
H-positive risk:  687 701 100 1078 441 107 1075 429 120 62 137 63 
H-negative risk:  701 687 1075 1078 429 441 107 100 137 120 63 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
94 new agents 
231 
disease_progression 
H-positive risk:  688 699 104 1067 447 107 1076 426 122 65 138 61 
H-negative risk:  699 688 1076 1067 426 447 107 104 138 122 61 65 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
232 
disease_progression 
H-positive risk:  688 698 102 1072 449 108 1085 416 121 65 134 62 
H-negative risk:  698 688 1085 1072 416 449 108 102 134 121 62 65 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
233 
disease_progression 
H-positive risk:  681 694 100 1076 454 106 1086 413 120 67 138 65 
H-negative risk:  694 681 1086 1076 413 454 106 100 138 120 65 67 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
234 
disease_progression 
H-positive risk:  681 693 98 1081 445 107 1095 409 118 67 142 64 
H-negative risk:  693 681 1095 1081 409 445 107 98 142 118 64 67 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
235 
disease_progression 
H-positive risk:  683 694 96 1082 449 106 1091 408 118 66 144 63 
H-negative risk:  694 683 1091 1082 408 449 106 96 144 118 63 66 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
236 
disease_progression 
H-positive risk:  678 688 95 1089 451 108 1087 412 121 63 145 63 
H-negative risk:  688 678 1087 1089 412 451 108 95 145 121 63 63 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
237 
disease_progression 
H-positive risk:  677 684 93 1086 456 107 1091 409 122 63 147 65 
H-negative risk:  684 677 1091 1086 409 456 107 93 147 122 65 63 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
238 
disease_progression 
H-positive risk:  676 686 95 1089 451 104 1088 413 124 60 149 65 
H-negative risk:  686 676 1088 1089 413 451 104 95 149 124 65 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
239 
disease_progression 
H-positive risk:  673 687 98 1089 456 101 1090 406 125 61 149 65 
H-negative risk:  687 673 1090 1089 406 456 101 98 149 125 65 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
240 
disease_progression 
H-positive risk:  677 685 96 1091 456 101 1097 394 126 62 151 64 
H-negative risk:  685 677 1097 1091 394 456 101 96 151 126 64 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
241 
disease_progression 
H-positive risk:  676 687 95 1089 454 99 1089 406 126 62 153 64 
H-negative risk:  687 676 1089 1089 406 454 99 95 153 126 64 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
242 
disease_progression 
H-positive risk:  681 685 97 1094 449 101 1078 407 125 63 155 65 
H-negative risk:  685 681 1078 1094 407 449 101 97 155 125 65 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
243 
disease_progression 
H-positive risk:  681 692 96 1087 453 100 1071 411 128 62 155 64 
H-negative risk:  692 681 1071 1087 411 453 100 96 155 128 64 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
244 
disease_progression 
H-positive risk:  677 699 99 1086 445 100 1082 408 127 61 153 63 
H-negative risk:  699 677 1082 1086 408 445 100 99 153 127 63 61 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
245 
disease_progression 
H-positive risk:  683 702 98 1083 438 102 1083 407 127 60 153 64 
H-negative risk:  702 683 1083 1083 407 438 102 98 153 127 64 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
246 
disease_progression 
H-positive risk:  688 708 101 1079 429 104 1082 409 124 60 154 62 
H-negative risk:  708 688 1082 1079 409 429 104 101 154 124 62 60 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
247 
disease_progression 
H-positive risk:  677 706 103 1074 433 106 1087 420 125 59 151 59 
H-negative risk:  706 677 1087 1074 420 433 106 103 151 125 59 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
248 
disease_progression 
H-positive risk:  670 699 108 1065 439 103 1101 422 125 59 151 58 
H-negative risk:  699 670 1101 1065 422 439 103 108 151 125 58 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
249 
disease_progression 
H-positive risk:  666 696 109 1068 441 105 1097 423 124 61 153 57 
H-negative risk:  696 666 1097 1068 423 441 105 109 153 124 57 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
250 
disease_progression 
H-positive risk:  667 693 106 1070 431 109 1101 426 124 62 156 55 
H-negative risk:  693 667 1101 1070 426 431 109 106 156 124 55 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
251 
disease_progression 
H-positive risk:  666 693 106 1074 430 110 1103 422 125 58 157 56 
H-negative risk:  693 666 1103 1074 422 430 110 106 157 125 56 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
252 
disease_progression 
H-positive risk:  662 694 106 1080 435 111 1097 418 126 58 157 56 
H-negative risk:  694 662 1097 1080 418 435 111 106 157 126 56 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
253 
disease_progression 
H-positive risk:  654 697 110 1079 424 115 1099 420 127 59 160 56 
H-negative risk:  697 654 1099 1079 420 424 115 110 160 127 56 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
254 
disease_progression 
H-positive risk:  650 689 111 1083 432 118 1106 413 124 59 156 59 
H-negative risk:  689 650 1106 1083 413 432 118 111 156 124 59 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
255 
disease_progression 
H-positive risk:  640 684 108 1085 439 117 1115 412 125 62 155 58 
H-negative risk:  684 640 1115 1085 412 439 117 108 155 125 58 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
256 
disease_progression 
H-positive risk:  641 684 108 1088 430 115 1106 425 127 64 156 56 
H-negative risk:  684 641 1106 1088 425 430 115 108 156 127 56 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
257 
disease_progression 
H-positive risk:  644 676 108 1087 432 112 1105 429 131 64 159 53 
H-negative risk:  676 644 1105 1087 429 432 112 108 159 131 53 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
258 
disease_progression 
H-positive risk:  645 670 106 1083 435 114 1108 429 131 62 162 55 
H-negative risk:  670 645 1108 1083 429 435 114 106 162 131 55 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
259 
disease_progression 
H-positive risk:  636 677 105 1090 429 110 1111 428 133 67 160 54 
H-negative risk:  677 636 1111 1090 428 429 110 105 160 133 54 67 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
260 
disease_progression 
H-positive risk:  633 677 102 1089 433 111 1111 427 134 65 165 53 
H-negative risk:  677 633 1111 1089 427 433 111 102 165 134 53 65 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
261 
disease_progression 
H-positive risk:  635 682 102 1094 434 114 1114 419 133 61 162 50 
H-negative risk:  682 635 1114 1094 419 434 114 102 162 133 50 61 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
262 
disease_progression 
H-positive risk:  642 688 100 1090 428 114 1112 421 135 61 160 49 
H-negative risk:  688 642 1112 1090 421 428 114 100 160 135 49 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
92 new agents 
263 
disease_progression 
H-positive risk:  642 688 102 1091 428 121 1114 419 130 60 158 47 
H-negative risk:  688 642 1114 1091 419 428 121 102 158 130 47 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
264 
disease_progression 
H-positive risk:  645 688 100 1082 434 122 1117 420 130 56 159 47 
H-negative risk:  688 645 1117 1082 420 434 122 100 159 130 47 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
265 
disease_progression 
H-positive risk:  636 691 99 1090 437 122 1117 425 125 57 155 46 
H-negative risk:  691 636 1117 1090 425 437 122 99 155 125 46 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
266 
disease_progression 
H-positive risk:  637 690 97 1081 442 122 1122 422 125 59 155 48 
H-negative risk:  690 637 1122 1081 422 442 122 97 155 125 48 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
267 
disease_progression 
H-positive risk:  643 691 99 1085 440 123 1110 420 124 61 155 49 
H-negative risk:  691 643 1110 1085 420 440 123 99 155 124 49 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
268 
disease_progression 
H-positive risk:  642 686 99 1079 442 124 1111 423 122 64 159 49 
H-negative risk:  686 642 1111 1079 423 442 124 99 159 122 49 64 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
269 
disease_progression 
H-positive risk:  640 688 99 1086 443 127 1101 425 122 65 152 52 
H-negative risk:  688 640 1101 1086 425 443 127 99 152 122 52 65 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
270 
disease_progression 
H-positive risk:  645 695 99 1086 449 126 1093 422 119 66 151 49 
H-negative risk:  695 645 1093 1086 422 449 126 99 151 119 49 66 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
271 
disease_progression 
H-positive risk:  645 690 102 1079 448 124 1099 427 122 67 148 49 
H-negative risk:  690 645 1099 1079 427 448 124 102 148 122 49 67 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
272 
disease_progression 
H-positive risk:  652 693 101 1083 451 122 1092 428 120 63 148 47 
H-negative risk:  693 652 1092 1083 428 451 122 101 148 120 47 63 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
273 
disease_progression 
H-positive risk:  643 695 102 1090 448 123 1097 428 119 63 148 44 
H-negative risk:  695 643 1097 1090 428 448 123 102 148 119 44 63 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
274 
disease_progression 
H-positive risk:  643 690 99 1095 451 119 1100 427 120 62 150 44 
H-negative risk:  690 643 1100 1095 427 451 119 99 150 120 44 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
275 
disease_progression 
H-positive risk:  640 701 97 1102 445 123 1101 418 118 63 149 43 
H-negative risk:  701 640 1101 1102 418 445 123 97 149 118 43 63 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
276 
disease_progression 
H-positive risk:  641 698 99 1106 437 121 1103 424 118 62 149 42 
H-negative risk:  698 641 1103 1106 424 437 121 99 149 118 42 62 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
91 new agents 
277 
disease_progression 
H-positive risk:  651 700 97 1097 433 118 1106 428 117 61 149 43 
H-negative risk:  700 651 1106 1097 428 433 118 97 149 117 43 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
278 
disease_progression 
H-positive risk:  653 696 99 1100 431 118 1106 418 118 62 155 44 
H-negative risk:  696 653 1106 1100 418 431 118 99 155 118 44 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
92 new agents 
279 
disease_progression 
H-positive risk:  654 686 99 1111 436 120 1110 407 121 61 151 44 
H-negative risk:  686 654 1110 1111 407 436 120 99 151 121 44 61 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
280 
disease_progression 
H-positive risk:  657 697 98 1109 434 118 1106 406 118 59 153 45 
H-negative risk:  697 657 1106 1109 406 434 118 98 153 118 45 59 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
281 
disease_progression 
H-positive risk:  663 688 100 1113 430 115 1103 409 122 59 152 46 
H-negative risk:  688 663 1103 1113 409 430 115 100 152 122 46 59 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
282 
disease_progression 
H-positive risk:  665 685 99 1112 432 119 1102 406 125 58 152 45 
H-negative risk:  685 665 1102 1112 406 432 119 99 152 125 45 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
283 
disease_progression 
H-positive risk:  666 689 100 1106 426 120 1111 402 125 57 153 45 
H-negative risk:  689 666 1111 1106 402 426 120 100 153 125 45 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
284 
disease_progression 
H-positive risk:  670 681 99 1110 430 118 1118 398 124 56 148 48 
H-negative risk:  681 670 1118 1110 398 430 118 99 148 124 48 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
285 
disease_progression 
H-positive risk:  678 686 101 1091 433 119 1114 402 123 58 148 47 
H-negative risk:  686 678 1114 1091 402 433 119 101 148 123 47 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
89 new agents 
286 
disease_progression 
H-positive risk:  683 688 102 1083 424 119 1118 410 126 54 147 46 
H-negative risk:  688 683 1118 1083 410 424 119 102 147 126 46 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
287 
disease_progression 
H-positive risk:  685 691 102 1083 421 115 1110 419 128 55 143 48 
H-negative risk:  691 685 1110 1083 419 421 115 102 143 128 48 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
288 
disease_progression 
H-positive risk:  688 690 104 1081 424 112 1112 415 129 54 144 47 
H-negative risk:  690 688 1112 1081 415 424 112 104 144 129 47 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
289 
disease_progression 
H-positive risk:  690 692 105 1080 418 116 1117 408 127 56 144 47 
H-negative risk:  692 690 1117 1080 408 418 116 105 144 127 47 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
91 new agents 
290 
disease_progression 
H-positive risk:  697 683 105 1086 416 113 1118 399 136 53 145 49 
H-negative risk:  683 697 1118 1086 399 416 113 105 145 136 49 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 82 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
291 
disease_progression 
H-positive risk:  706 689 102 1076 416 112 1113 401 142 51 142 50 
H-negative risk:  689 706 1113 1076 401 416 112 102 142 142 50 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
292 
disease_progression 
H-positive risk:  706 692 103 1073 421 113 1110 398 142 52 141 49 
H-negative risk:  692 706 1110 1073 398 421 113 103 141 142 49 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
293 
disease_progression 
H-positive risk:  700 691 103 1070 430 113 1112 397 137 56 143 48 
H-negative risk:  691 700 1112 1070 397 430 113 103 143 137 48 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
294 
disease_progression 
H-positive risk:  701 699 102 1065 430 114 1107 397 140 54 138 53 
H-negative risk:  699 701 1107 1065 397 430 114 102 138 140 53 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
295 
disease_progression 
H-positive risk:  700 694 99 1073 436 111 1100 402 138 55 140 52 
H-negative risk:  694 700 1100 1073 402 436 111 99 140 138 52 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
80 new agents 
296 
disease_progression 
H-positive risk:  704 687 101 1077 433 111 1093 406 137 56 144 51 
H-negative risk:  687 704 1093 1077 406 433 111 101 144 137 51 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 81 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
297 
disease_progression 
H-positive risk:  704 687 100 1075 432 113 1093 407 138 54 144 53 
H-negative risk:  687 704 1093 1075 407 432 113 100 144 138 53 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 82 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
298 
disease_progression 
H-positive risk:  702 691 100 1080 427 114 1082 413 136 54 147 54 
H-negative risk:  691 702 1082 1080 413 427 114 100 147 136 54 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 82 14 

clinical_engagement 
diagnosis 
demography 
75 new agents 
299 
disease_progression 
H-positive risk:  696 693 100 1082 432 111 1076 422 136 54 145 53 
H-negative risk:  693 696 1076 1082 422 432 111 100 145 136 53 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 83 14 

clinical_engagement 
diagnosis 
demography 
63 new agents 
300 
disease_progression 
H-positive risk:  690 699 100 1069 438 109 1085 420 138 51 148 53 
H-negative risk:  699 690 1085 1069 420 438 109 100 148 138 53 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 85 13 

clinical_engagement 
diagnosis 
demography 
86 new agents 
301 
disease_progression 
H-positive risk:  682 704 99 1064 439 107 1096 416 137 55 148 53 
H-negative risk:  704 682 1096 1064 416 439 107 99 148 137 53 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 85 13 

clinical_engagement 
diagnosis 
demography 
79 new agents 
302 
disease_progression 
H-positive risk:  686 700 99 1079 437 102 1094 408 138 54 152 51 
H-negative risk:  700 686 1094 1079 408 437 102 99 152 138 51 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 84 13 

clinical_engagement 
diagnosis 
demography 
92 new agents 
303 
disease_progression 
H-positive risk:  691 698 97 1076 434 104 1087 411 143 55 152 52 
H-negative risk:  698 691 1087 1076 411 434 104 97 152 143 52 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 82 15 

clinical_engagement 
diagnosis 
demography 
78 new agents 
304 
disease_progression 
H-positive risk:  676 696 97 1090 431 105 1095 410 143 54 151 52 
H-negative risk:  696 676 1095 1090 410 431 105 97 151 143 52 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
305 
disease_progression 
H-positive risk:  688 698 97 1087 431 102 1094 404 144 53 151 51 
H-negative risk:  698 688 1094 1087 404 431 102 97 151 144 51 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
306 
disease_progression 
H-positive risk:  683 704 97 1078 442 101 1098 401 146 51 147 52 
H-negative risk:  704 683 1098 1078 401 442 101 97 147 146 52 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
70 new agents 
307 
disease_progression 
H-positive risk:  686 697 101 1077 442 98 1091 409 147 52 147 53 
H-negative risk:  697 686 1091 1077 409 442 98 101 147 147 53 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
86 new agents 
308 
disease_progression 
H-positive risk:  691 691 101 1080 439 98 1094 405 145 54 147 55 
H-negative risk:  691 691 1094 1080 405 439 98 101 147 145 55 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
309 
disease_progression 
H-positive risk:  688 691 102 1087 437 97 1087 406 147 56 148 54 
H-negative risk:  691 688 1087 1087 406 437 97 102 148 147 54 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
310 
disease_progression 
H-positive risk:  689 687 101 1092 439 96 1080 412 147 58 144 55 
H-negative risk:  687 689 1080 1092 412 439 96 101 144 147 55 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
93 new agents 
311 
disease_progression 
H-positive risk:  689 690 103 1097 435 95 1074 408 148 58 146 57 
H-negative risk:  690 689 1074 1097 408 435 95 103 146 148 57 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 87 15 

clinical_engagement 
diagnosis 
demography 
75 new agents 
312 
disease_progression 
H-positive risk:  694 698 102 1087 436 96 1071 405 147 59 147 58 
H-negative risk:  698 694 1071 1087 405 436 96 102 147 147 58 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
313 
disease_progression 
H-positive risk:  702 702 101 1086 426 98 1058 413 148 60 149 57 
H-negative risk:  702 702 1058 1086 413 426 98 101 149 148 57 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
314 
disease_progression 
H-positive risk:  701 710 100 1080 420 99 1066 416 145 57 151 55 
H-negative risk:  710 701 1066 1080 416 420 99 100 151 145 55 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 82 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
315 
disease_progression 
H-positive risk:  702 710 101 1077 423 100 1062 425 143 55 146 56 
H-negative risk:  710 702 1062 1077 425 423 100 101 146 143 56 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
316 
disease_progression 
H-positive risk:  697 704 100 1086 418 103 1060 433 141 54 148 56 
H-negative risk:  704 697 1060 1086 433 418 103 100 148 141 56 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
317 
disease_progression 
H-positive risk:  701 704 102 1085 410 103 1061 433 143 55 149 54 
H-negative risk:  704 701 1061 1085 433 410 103 102 149 143 54 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 83 17 

clinical_engagement 
diagnosis 
demography 
59 new agents 
318 
disease_progression 
H-positive risk:  703 700 102 1095 401 106 1057 433 143 53 151 56 
H-negative risk:  700 703 1057 1095 433 401 106 102 151 143 56 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
319 
disease_progression 
H-positive risk:  702 696 101 1095 409 109 1053 432 143 53 152 55 
H-negative risk:  696 702 1053 1095 432 409 109 101 152 143 55 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
320 
disease_progression 
H-positive risk:  708 695 98 1092 409 109 1056 427 146 51 155 54 
H-negative risk:  695 708 1056 1092 427 409 109 98 155 146 54 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
321 
disease_progression 
H-positive risk:  706 694 98 1095 402 108 1081 419 142 53 150 52 
H-negative risk:  694 706 1081 1095 419 402 108 98 150 142 52 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
322 
disease_progression 
H-positive risk:  708 684 98 1093 412 107 1073 429 142 55 147 52 
H-negative risk:  684 708 1073 1093 429 412 107 98 147 142 52 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
323 
disease_progression 
H-positive risk:  704 687 100 1096 414 109 1067 424 142 57 148 52 
H-negative risk:  687 704 1067 1096 424 414 109 100 148 142 52 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
324 
disease_progression 
H-positive risk:  710 685 100 1098 408 109 1075 424 141 54 144 52 
H-negative risk:  685 710 1075 1098 424 408 109 100 144 141 52 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
325 
disease_progression 
H-positive risk:  707 692 102 1087 408 110 1078 424 142 54 145 51 
H-negative risk:  692 707 1078 1087 424 408 110 102 145 142 51 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
326 
disease_progression 
H-positive risk:  707 693 100 1089 405 110 1079 421 143 53 150 50 
H-negative risk:  693 707 1079 1089 421 405 110 100 150 143 50 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
327 
disease_progression 
H-positive risk:  712 694 101 1097 403 111 1075 415 140 55 148 49 
H-negative risk:  694 712 1075 1097 415 403 111 101 148 140 49 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
328 
disease_progression 
H-positive risk:  712 693 98 1102 401 111 1072 417 140 56 149 49 
H-negative risk:  693 712 1072 1102 417 401 111 98 149 140 49 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
329 
disease_progression 
H-positive risk:  717 690 100 1101 396 109 1078 417 139 56 148 49 
H-negative risk:  690 717 1078 1101 417 396 109 100 148 139 49 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
330 
disease_progression 
H-positive risk:  712 697 102 1099 395 107 1085 416 134 57 149 47 
H-negative risk:  697 712 1085 1099 416 395 107 102 149 134 47 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
331 
disease_progression 
H-positive risk:  716 694 103 1103 394 108 1078 416 135 56 151 46 
H-negative risk:  694 716 1078 1103 416 394 108 103 151 135 46 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
332 
disease_progression 
H-positive risk:  707 695 103 1095 400 109 1091 413 134 54 149 50 
H-negative risk:  695 707 1091 1095 413 400 109 103 149 134 50 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
333 
disease_progression 
H-positive risk:  708 698 102 1090 402 109 1092 413 134 57 146 49 
H-negative risk:  698 708 1092 1090 413 402 109 102 146 134 49 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
334 
disease_progression 
H-positive risk:  695 700 102 1088 403 112 1106 410 133 56 144 51 
H-negative risk:  700 695 1106 1088 410 403 112 102 144 133 51 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
335 
disease_progression 
H-positive risk:  690 698 101 1097 401 114 1104 404 133 57 144 57 
H-negative risk:  698 690 1104 1097 404 401 114 101 144 133 57 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
336 
disease_progression 
H-positive risk:  684 694 101 1104 399 115 1106 408 132 57 140 60 
H-negative risk:  694 684 1106 1104 408 399 115 101 140 132 60 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
337 
disease_progression 
H-positive risk:  684 695 99 1108 405 115 1097 404 134 57 144 58 
H-negative risk:  695 684 1097 1108 404 405 115 99 144 134 58 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
338 
disease_progression 
H-positive risk:  679 693 98 1112 406 113 1095 409 137 55 143 60 
H-negative risk:  693 679 1095 1112 409 406 113 98 143 137 60 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
339 
disease_progression 
H-positive risk:  679 700 96 1111 401 114 1088 416 137 54 144 60 
H-negative risk:  700 679 1088 1111 416 401 114 96 144 137 60 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
50 new agents 
340 
disease_progression 
H-positive risk:  674 694 97 1101 415 114 1092 414 136 57 147 59 
H-negative risk:  694 674 1092 1101 414 415 114 97 147 136 59 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
341 
disease_progression 
H-positive risk:  670 693 99 1101 426 109 1090 418 138 55 143 58 
H-negative risk:  693 670 1090 1101 418 426 109 99 143 138 58 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
342 
disease_progression 
H-positive risk:  675 692 96 1101 426 108 1085 417 140 55 144 61 
H-negative risk:  692 675 1085 1101 417 426 108 96 144 140 61 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
343 
disease_progression 
H-positive risk:  673 698 96 1095 427 108 1080 422 142 52 146 61 
H-negative risk:  698 673 1080 1095 422 427 108 96 146 142 61 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
344 
disease_progression 
H-positive risk:  670 701 99 1093 424 106 1085 426 143 51 141 61 
H-negative risk:  701 670 1085 1093 426 424 106 99 141 143 61 51 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
345 
disease_progression 
H-positive risk:  670 709 99 1096 414 103 1084 429 145 51 138 62 
H-negative risk:  709 670 1084 1096 429 414 103 99 138 145 62 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
346 
disease_progression 
H-positive risk:  667 701 101 1106 412 100 1088 426 148 50 140 61 
H-negative risk:  701 667 1088 1106 426 412 100 101 140 148 61 50 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
347 
disease_progression 
H-positive risk:  671 697 101 1121 405 102 1073 425 148 53 140 64 
H-negative risk:  697 671 1073 1121 425 405 102 101 140 148 64 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
348 
disease_progression 
H-positive risk:  665 687 100 1127 407 102 1077 430 147 54 138 66 
H-negative risk:  687 665 1077 1127 430 407 102 100 138 147 66 54 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
349 
disease_progression 
H-positive risk:  664 677 97 1136 410 100 1075 436 147 52 140 66 
H-negative risk:  677 664 1075 1136 436 410 100 97 140 147 66 52 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
350 
disease_progression 
H-positive risk:  656 680 98 1129 417 100 1075 436 148 52 144 65 
H-negative risk:  680 656 1075 1129 436 417 100 98 144 148 65 52 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 65 19 

clinical_engagement 
diagnosis 
demography 
91 new agents 
351 
disease_progression 
H-positive risk:  664 678 100 1117 422 98 1070 439 148 55 146 63 
H-negative risk:  678 664 1070 1117 439 422 98 100 146 148 63 55 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 65 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
352 
disease_progression 
H-positive risk:  666 675 98 1114 422 97 1074 445 147 52 147 63 
H-negative risk:  675 666 1074 1114 445 422 97 98 147 147 63 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 68 20 

clinical_engagement 
diagnosis 
demography 
60 new agents 
353 
disease_progression 
H-positive risk:  662 674 100 1115 420 96 1076 447 147 54 149 60 
H-negative risk:  674 662 1076 1115 447 420 96 100 149 147 60 54 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
354 
disease_progression 
H-positive risk:  673 670 98 1112 420 96 1072 452 150 50 147 60 
H-negative risk:  670 673 1072 1112 452 420 96 98 147 150 60 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
355 
disease_progression 
H-positive risk:  678 668 97 1117 421 96 1062 456 148 51 149 57 
H-negative risk:  668 678 1062 1117 456 421 96 97 149 148 57 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
356 
disease_progression 
H-positive risk:  679 657 99 1120 415 96 1071 454 146 52 153 58 
H-negative risk:  657 679 1071 1120 454 415 96 99 153 146 58 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
357 
disease_progression 
H-positive risk:  689 664 99 1121 423 99 1056 446 142 52 154 55 
H-negative risk:  664 689 1056 1121 446 423 99 99 154 142 55 52 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
87 new agents 
358 
disease_progression 
H-positive risk:  692 667 101 1101 431 100 1054 442 147 54 157 54 
H-negative risk:  667 692 1054 1101 442 431 100 101 157 147 54 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
359 
disease_progression 
H-positive risk:  686 667 102 1100 434 98 1063 439 147 56 156 52 
H-negative risk:  667 686 1063 1100 439 434 98 102 156 147 52 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
360 
disease_progression 
H-positive risk:  689 677 103 1092 437 97 1059 432 145 59 157 53 
H-negative risk:  677 689 1059 1092 432 437 97 103 157 145 53 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
Time difference of 15.63858 mins
This is task 18
